HHS Secretary Alex Azar told the Senate health committee Tuesday (June 12) that he believes the administration has the authority to mandate disclosure of list prices in direct-to-consumer ads, but added that he welcomes congressional action on the issue given he expects the idea will be challenged in court. Senate health committee Democrats were quick to point out that no Republicans have cosponsored the Democratic-sponsored “Drug-price Transparency in Communications (DTC) Act of 2017,” which would mandate such disclosures. “I’m particularly...